Scarring is a normal part of tissue repair, but the final appearance depends on wound depth, inflammation, collagen formation, genetics and the location of the injury. Some scars gradually flatten and fade, while hypertrophic scars remain raised and keloids can extend beyond the original wound. This makes scar care a clinical issue as well as a cosmetic concern.
For OTC scar treatment products market, the distinction matters because consumers may purchase similar-looking products for very different conditions. The American Academy of Dermatology advises identifying the type of scar before selecting treatment, particularly when a scar causes pain, itching or restricted movement.
Why Silicone Has Become a Central Part of Scar Care?
-
Silicone gels and sheets are widely used non-invasive options for managing raised scars.
-
They create a protective layer over healed skin and help maintain hydration. Sheets suit some larger or flatter areas, whereas gels can be more convenient on visible areas or body contours.
-
A 2023 systematic review examined 30 studies of silicone gel-based products published between 1991 and 2022.
-
Most reported improvement in at least one scar characteristic, although limitations in study design, sample sizes and follow-up periods affected the strength of the evidence.
-
The findings support continued clinical interest without establishing that every formulation works equally well.
From Surgical Incisions to Everyday Skin Concerns
Post-operative recovery is an important application for scar management products. Following procedures such as caesarean delivery, orthopaedic surgery or other operations, patients may ask how to make a healed incision less noticeable. Clinicians typically emphasize appropriate wound closure, infection prevention and follow-up before introducing scar-specific products.
Acne-related scarring presents a different situation. Depressed acne scars involve changes in the underlying skin structure and may require professional procedures rather than an over-the-counter gel. Raised scars, pigmentation changes and persistent redness also need to be distinguished because they do not respond identically to treatment.
These differences create a need for clearer product descriptions and practical guidance that help consumers understand what a product is designed to address.
What Recent Clinical Studies Are Revealing?
Recent evidence reinforces the need to evaluate scar treatments by scar type and clinical outcome. A randomized, double-blinded study published in 2025 examined silicone gel against petrolatum after eyelid surgery. Across 192 eyelids from 96 patients, researchers found no significant differences between the treatments in scar appearance, itching, pain or firmness during the study period. This result illustrates why findings from one anatomical site should not automatically be generalized to every scar.
-
A 2026 systematic review and meta-analysis also examined silicone gels for hypertrophic scars, assessing randomized trials and highlighting continuing questions about comparative effectiveness.
-
The broader lesson for product developers is that clinical evidence should support specific claims rather than blanket promises of scar removal.
Ingredient Claims Need More Than a Compelling Label
Scar care products may contain silicone, onion extract, vitamin E, moisturizers or combinations of ingredients. However, evidence differs substantially between formulations. The American Academy of Dermatology notes that research supporting non-prescription ingredients such as onion extract and vitamin E remains limited.
Manufacturers can help consumers by specifying the intended scar type, instructions for application, expected treatment duration and known precautions. Claims such as “removes every scar” can create unrealistic expectations because established scars cannot always be eliminated, and some require specialist treatment.
Want to learn more about the report? Check out our latest updated version for free: https://www.24lifesciences.com/otc-scar-treatment-products-market-14300
Product Safety and Regulatory Expectations in India
-
India's Central Drugs Standard Control Organization oversees cosmetics regulation under the applicable legal framework, including the Cosmetics Rules, 2020.
-
Imported cosmetics must meet relevant registration requirements, and cosmetic claims must not mislead consumers.
-
The regulatory classification of an individual scar product depends on its intended use and claims, so not every product should automatically be treated as an ordinary cosmetic.
-
For manufacturers and distributors, clear labelling, traceable ingredients, appropriate safety information and evidence-backed claims are important parts of responsible product development.
-
These considerations are especially relevant when products are sold through pharmacies, online marketplaces and international retail channels.
The Next Chapter in Everyday Scar Management
OTC scar treatment products market sits at the intersection of dermatology, post-operative care and consumer skincare. Silicone gels and sheets remain established options, but the evidence is not uniform across all products or scar types. Better clinical studies, more precise product labelling and clearer patient education can help bridge the gap between consumer expectations and actual outcomes.
For healthcare professionals, manufacturers and retailers, the priority is not to promise a scar-free result. It is to make appropriate scar care easier to understand, safer to use and better aligned with the needs of people recovering from injuries, burns and surgery.